Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 204, Issue 6, Pages 1405-1416Publisher
ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20062363
Keywords
-
Categories
Funding
- Medical Research Council [G0501963] Funding Source: researchfish
- MRC [G0501963] Funding Source: UKRI
- Intramural NIH HHS Funding Source: Medline
- Medical Research Council [G0501963] Funding Source: Medline
Ask authors/readers for more resources
Vaccinia virus immunization provides lifelong protection against smallpox, but the mechanisms of this exquisite protection are unknown. We used polychromatic flow cytometry to characterize the functional and phenotypic profile of CD8(+) T cells induced by vaccinia virus immunization in a comparative vaccine trial of modified vaccinia virus Ankara (MVA) versus Dryvax immunization in which protection was assessed against subsequent Dryvax challenge. Vaccinia virus - specific CD8(+) T cells induced by both MVA and Dryvax were highly polyfunctional; they degranulated and produced interferon gamma, interleukin 2, macrophage inflammatory protein 1 beta, and tumor necrosis factor.. after antigenic stimulation. Responding CD8(+) T cells exhibited an unusual phenotype (CD45RO - CD27(intermediate)). The unique phenotype and high degree of polyfunctionality induced by vaccinia virus also extended to inserted HIV gene products of recombinant NYVAC. This quality of the CD8(+) T cell response may be at least partially responsible for the profound efficacy of these vaccines in protection against smallpox and serves as a benchmark against which other vaccines can be evaluated.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available